BIOTECH AUSTRIA

Our president Peter Llewellyn-Davies said some controversial things in this podcast. Do you follow his opinion, do you follow the trend?

Participants from 13 countries met last week in Innsbruck to celebrate Austrian Biotechnology at the 2nd BIOTECH SUMMIT AUSTRIA. Bringing together leaders in Austrian biotech, pharma, service providers and many more was almost like meeting up with old and making new friends. The wonderful atmosphere at all events, the hike, the panel discussions with experts and key note speeches as well as interactions via the partnering system was unbelievable. The party was amazing fun and topped it all. Great to have you there and see you next year in Graz! #BSA24 BIOTECH AUSTRIA  Standortagentur Tirol Human.technology Styria GmbH Musik: Early Hours, Musiker: @iksonmusic

After a successful networking session during our 1:1 Partnering, the day continued with a roundtable moderated by Georg Kääb on the topic “How to exit - making real money from Biotech“. We thank Alexander Belcredi, Lisa Egerer and Nikolaus Krall for the lively discussion and valuable insights on the subject. In the final fireside chat of our event, Alexander von Gabain and Peter Llewellyn-Davies shared their extensive experience and provided fascinating insights on “Mindset, innovation, science, entrepreneurship and again mindset”. Many thanks to both of them for their contributions! In cooperation with: Standortagentur Tirol and Human.technology Styria GmbH #BSA24 #biotech #network #innovation #mindset

Today’s BIOTECH SUMMIT AUSTRIA kicked off with exciting talks on positioning Austria for success and strategic measures to boost the biotech industry by Johanna Grames und Thomas Moser of the BIOTECH AUSTRIA Taskforce Strategy Team 💬 This was followed by a keynote from Nicole Daniela Schlautmann of MSD Österreich on the subject of “From science to patient care: bridging innovation across science, biotech, and pharma”. Thank you for the valuable insights and discussion! The day continued with a panel on the topic of Venture Capital: “The current funding environment is challenging, but not for all – what are success factors?", moderated by Peter Llewellyn-Davies. Many thanks to Florian Schuster, Hubert Birner, Ingrid Kelly Spillmann, Matthias Kromayer and Rainer Strohmenger for sharing their perspectives on the criteria that lead to funding success. Next, the second part of our Startup Pitches began. We were part of the excitement as entrepreneurs showcased their vision, passion, and potential, seeking investment, partnerships, and support to bring their innovations to life. Thanks to Cycuria Therapeutics, Enzyan Biocatalysis GmbH, kamosys, SimVantage and YGION Biomedical for their incredible pitches! In cooperation with: Standortagentur Tirol and Human.technology Styria GmbH #BSA24 #biotech #biotechnology #patientcare #pharma #science

Wrapping up the day with the first round of Startup Pitches! It was inspiring to witness the next wave of innovation in the biotechnology industry as emerging startups presented their groundbreaking ideas and solutions. From cutting-edge therapeutics to revolutionary technologies, these startups showcased their potential to reshape the future of biotech. 🚀 Thank you Angios FlexCo, KinCon biolabs, QUBICON, Sola Diagnostics GmbH, syndena for your incredible pitches! We would also like to thank Michael Ginner from our premium sponsor KPMG Austria for the short talk about optimizing biotech operations with AI Solutions. The final Keynote of the day sparked a fantastic discussion on the topic: “Innovation, capital and courage – what do we need to found a Biotech successfully?”, moderated by Gregor Wick. Many thanks to Josef Penninger and Severin Schwan for your valuable insights and contributions to our sector! Thank you for an amazing first day at the BIOTECH SUMMIT AUSTRIA. We look forward to more exciting topics tomorrow and to a great party tonight! 🎉💡 In cooperation with: Standortagentur Tirol und Human.technology Styria GmbH #BSA24 #biotech #AI #innovation #startup #biotech #biotechnology

After a highly successful 1:1 partnering session with industry leaders, innovators, and potential collaborators, where synergies were explored and strategic partnerships were established, the first half of the afternoon continued with insightful talks. 💬 The session began with a talk and presentation by Dr. Andrea Pramböck from KPMG Austria , focusing on the topic of “EU funding - Boon or Burden“ offering valuable insights on possibilities and opportunities of EU funding for the biotech sector. Additionally, there were short talks today from our premium sponsors Johanna Grames from AOP Health and Alexander Gunacker, from Bartelt GmbH. Thank you for your presentations. The afternoon concluded with a networking session over coffee, where participants had the opportunity to further discuss the day’s themes and connect with peers, enriching the overall experience. In cooperation with: Standortagentur Tirol and Human.technology Styria GmbH #BSA24 #biotechnology #EUfunding

The first exciting morning is coming to an end. The opening of the BIOTECH SUMMIT AUSTRIA 2024 was hosted by Peter Llewellyn-Davies from BIOTECH AUSTRIA, Klaus Weinberger from Health Hub Tirol and Lejla Pock from Human.technology Styria GmbH. The event kicked off with an engaging presentation on the topic "Seed and succeed – how to build a multibillion dollar biotech – and exit!" Thank you, Patrick Trojer, from TRIANA Biomedicines, for the valuable insights into the subject. The day continued with a panel specializing in upcoming trends in the biotech sector. A big thank you to Doris Wilflingseder, Guido Gualdoni, Herbert Tilg, Ralf Huss and Sophie Zettl for sharing future trends and contributing to the valuable discussion. In cooperation with: Standortagentur Tirol, Human.technology Styria GmbH #BSA24 #trends #future #panels #biotech #technology

After a fantastic hike from the mountain station of the Hungerburgbahn to Umbrüggler Alm with stunning views along the way, we had the chance to enjoy regional specialties and network in a relaxed atmosphere. ⛰️ It was a great opportunity to connect with new people from the industry and engage in interesting conversations. A truly wonderful start to the BIOTECH SUMMIT AUSTRIA 2024! #BSA24 #networking #hiking #biotechnology #austria

Biotech: Langer Atem, großer Impact Zum Artikel: https://lnkd.in/dqjAyn_U Sie entwickeln Therapien für bislang unheilbare Krankheiten und lösen Probleme, die so alt sind wie die Menschheit selbst: Der potenzielle Impact von Biotech-Startups ist enorm. Dafür gelten für sie andere Spielregeln als für Startups in anderen Branchen. Wir sprachen dazu mit (im Bild vlnr.) Peter Llewellyn-Davies, Präsident BIOTECH AUSTRIA & CEO invIOs INNOVATIVE IMMUNO-ONCOLOGY, Anna Orlova🇺🇦, Gründerin und CEO RIANA Therapeutics, und Christopher Trummer, Co-Founder Venga Ventures. “Es gibt eine starke regulatorische Schranke, es muss extrem lange mit vielen Vorschriften getestet werden. Wenn man das geschafft hat, hat man ein Produkt“, sagt Llewellyn-Davies.

📣 Speaker Announcement for the 2nd BIOTECH SUMMIT AUSTRIA! 📣 Innovation comes from science and the renowned experts in this panel will provide us with insights into the upcoming trends in biotech at this week's sold out #BSA24! We proudly present: Guido Gualdoni (G.ST Antivirals ), Ralf Huss (BioM Biotech Cluster Development GmbH), Herbert Tilg (Medizinische Universität Innsbruck), Doris Wilflingseder (Veterinärmedizinische Universität Wien), and Sophie Zettl (YGION Biomedical) In cooperation with: Standortagentur Tirol and Human.technology Styria GmbH